A detailed history of Dunhill Financial, LLC transactions in Organon & Co. stock. As of the latest transaction made, Dunhill Financial, LLC holds 24 shares of OGN stock, worth $349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 24 -0.0%
Holding current value
$349
Previous $487,000 5.75%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$17.45 - $21.96 $17 - $21
1 Added 4.35%
24 $487,000
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $55 - $75
4 Added 21.05%
23 $431,000
Q4 2023

Feb 12, 2024

BUY
$10.95 - $17.32 $208 - $329
19 New
19 $279,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.